GlassScriptPhysician profile
Brian C Lewis
NPI 1124000419
$16,061.07
in general payments reported to CMS, 2019-2025
14 companies · $38.47 in 2025
The $38.47 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $41.26 · 2021: $205 · 2022: $9,928 · 2023: $2,341 · 2024: $3,376 · 2025: $38.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,873 · Education: $1,000 · Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,873.09 |
| Education | $1,000.00 |
| Food and Beverage | $882.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,487.76 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Stryker Corporation | $3,781.99 | 2022-2024 | Salvation, Na, Inspace |
| Davol INC. | $314.67 | 2019-2023 | Phasix Mesh |
| Boston Scientific Corporation | $161.49 | 2024 | Spyglass Discover |
| Smith+Nephew, INC. | $48.74 | 2019-2024 | Collagenase Santyl |
| Tela Bio, INC. | $45.23 | 2024 | Ovitex 2s |
| Takeda Pharmaceuticals U.S.A., INC. | $38.54 | 2020-2023 | Gattex |
| Pacira Pharmaceuticals Incorporated | $38.47 | 2025 | Exparel |
| Aroa Biosurgery Incorporated | $34.70 | 2019-2020 | |
| Organogenesis INC. | $30.03 | 2021 | |
| Olympus America INC. | $28.73 | 2019-2020 | |
| Shire North American Group INC | $17.23 | 2019 | |
| Allergan, INC. | $16.81 | 2021 | |
| Heron Therapeutics, INC. | $16.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.